The story of Viagra and its creator , copyright, presents a complex picture for cautious investors. While the blockbuster drug initially produced enormous profits , its protection has ended, leading to competing alternatives flooding the market . This decline in cost presents a substantial obstacle for copyright and any portfolio considering a sign